Researchers have made significant strides in understanding the role of long noncoding RNAs (lncRNAs) in aging and cellular senescence, with a new study employing a Perturb-seq-based CRISPR–dCas9–KRAB knockdown system combined with single-nucleus multiomics profiling. This comprehensive analysis focused on 32 high-abundance lncRNAs associated with aging and senescence, revealing their intricate regulatory functions in transcriptional and epigenetic processes. Notably, the study identified HOTAIRM1, an lncRNA linked to DNA repair, which plays a crucial role in stabilizing DNA repair mechanisms through interactions with BANF1 and p53.

The implications of these findings are profound for the longevity and healthspan research community. By elucidating the regulatory roles of previously uncharacterized lncRNAs, the study opens new avenues for therapeutic interventions targeting age-related diseases. The ability to modulate lncRNA activity could lead to innovative strategies for enhancing cellular repair mechanisms and potentially mitigating the effects of aging on tissue integrity, particularly in contexts such as pulmonary fibrosis, where HOTAIRM1 overexpression demonstrated protective effects in aged mouse lungs.

A key takeaway from this research is the potential for lncRNAs to serve as therapeutic targets in the treatment of age-related conditions. As the field shifts towards a more nuanced understanding of molecular aging processes, lncRNAs like HOTAIRM1 could be pivotal in developing novel longevity therapeutics, underscoring the importance of integrating multiomics approaches to uncover the complexities of aging biology.

Source: nature.com